C.R. Hansen

2.8k total citations · 1 hit paper
40 papers, 2.0k citations indexed

About

C.R. Hansen is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology. According to data from OpenAlex, C.R. Hansen has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 9 papers in Endocrinology. Recurrent topics in C.R. Hansen's work include Cystic Fibrosis Research Advances (23 papers), Infections and bacterial resistance (9 papers) and Neonatal Respiratory Health Research (8 papers). C.R. Hansen is often cited by papers focused on Cystic Fibrosis Research Advances (23 papers), Infections and bacterial resistance (9 papers) and Neonatal Respiratory Health Research (8 papers). C.R. Hansen collaborates with scholars based in Denmark, Sweden and Germany. C.R. Hansen's co-authors include Niels Høiby, Tacjana Pressler, Peter Østrup Jensen, Thomas Bjarnsholt, Michael Givskov, Claus Bøgelund Andersen, Oana Ciofu, Helle Krogh Johansen, Mette Kolpen and Claus Moser and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Thorax.

In The Last Decade

C.R. Hansen

35 papers receiving 2.0k citations

Hit Papers

Pseudomonas aeruginosa biofilms in the respiratory tract ... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
    2009 612 citations Thomas Bjarnsholt, Peter Østrup Jensen et al. Pediatric Pulmonology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.R. Hansen Denmark 20 1.0k 970 474 406 385 40 2.0k
Valerie Waters Canada 25 1.0k 1.0× 982 1.0× 348 0.7× 488 1.2× 407 1.1× 64 2.2k
Yvonne Yau Canada 27 872 0.9× 1.2k 1.3× 366 0.8× 375 0.9× 493 1.3× 67 2.2k
Miles Denton United Kingdom 11 601 0.6× 790 0.8× 682 1.4× 366 0.9× 262 0.7× 22 1.8k
Jim Manos Australia 21 764 0.8× 351 0.4× 197 0.4× 377 0.9× 153 0.4× 42 1.4k
Mette Kolpen Denmark 23 929 0.9× 351 0.4× 224 0.5× 343 0.8× 224 0.6× 45 1.5k
Chelsie E. Armbruster United States 22 690 0.7× 248 0.3× 415 0.9× 348 0.9× 786 2.0× 46 2.0k
James E. A. Zlosnik Canada 25 877 0.9× 755 0.8× 341 0.7× 366 0.9× 192 0.5× 52 1.7k
Pavel Dřevı́nek Czechia 27 611 0.6× 1.5k 1.5× 356 0.8× 205 0.5× 342 0.9× 105 2.6k
Maskit Bar‐Meir Israel 16 541 0.5× 344 0.4× 157 0.3× 311 0.8× 181 0.5× 46 1.3k
Dan Takeuchi Japan 30 244 0.2× 436 0.4× 247 0.5× 356 0.9× 359 0.9× 84 2.1k

Countries citing papers authored by C.R. Hansen

Since Specialization
Citations

This map shows the geographic impact of C.R. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Hansen more than expected).

Fields of papers citing papers by C.R. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.R. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Hansen. The network helps show where C.R. Hansen may publish in the future.

Co-authorship network of co-authors of C.R. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of C.R. Hansen. A scholar is included among the top collaborators of C.R. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.R. Hansen. C.R. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michelsen, Jens, et al.. (2025). Remote monitoring of cystic fibrosis lung disease in children and young adults. Journal of Cystic Fibrosis. 24(4). 704–709.
2.
Eklund, Erik A., et al.. (2025). The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 81(1). 74–81.
3.
Imberg, Henrik, et al.. (2024). Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study. Pediatric Pulmonology. 59(11). 2967–2975. 4 indexed citations
4.
5.
Hansen, C.R., et al.. (2023). Short-term exposure to zinc- and copper-containing welding fumes: Effects on pulmonary function in humans. Journal of Trace Elements in Medicine and Biology. 78. 127169–127169. 5 indexed citations
6.
7.
Hansen, C.R., Marita Gilljam, Hanne Vebert Olesen, et al.. (2021). Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections. Acta Paediatrica. 110(9). 2607–2609. 4 indexed citations
8.
9.
Hansen, C.R., et al.. (2019). A survey of the physiotherapy treatment methods for infants hospitalised with acute airway infections in Sweden. European Journal of Physiotherapy. 23(3). 149–156. 4 indexed citations
10.
Skov, Marianne, C.R. Hansen, & Tacjana Pressler. (2019). Cystic fibrosis – an example of personalized and precision medicine. Apmis. 127(5). 352–360. 29 indexed citations
11.
Qvist, Tavs, David Taylor‐Robinson, Elisabeth Waldmann, et al.. (2015). Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis. 15(3). 380–385. 103 indexed citations
12.
Kolpen, Mette, Michael Kühl, Thomas Bjarnsholt, et al.. (2014). Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection. PLoS ONE. 9(1). e84353–e84353. 73 indexed citations
13.
Qvist, Tavs, Marita Gilljam, Bodil Jönsson, et al.. (2014). Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. Journal of Cystic Fibrosis. 14(1). 46–52. 90 indexed citations
14.
Ridderberg, Winnie, C.R. Hansen, Niels Høiby, et al.. (2013). Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. Journal of Cystic Fibrosis. 12(6). 638–643. 48 indexed citations
15.
Hansen, C.R., Tacjana Pressler, Winnie Ridderberg, Helle Krogh Johansen, & Marianne Skov. (2013). Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to-patient contact. Journal of Cystic Fibrosis. 12(6). 609–615. 27 indexed citations
16.
Hansen, C.R.. (2012). Stenotrophomonas maltophilia. Current Opinion in Pulmonary Medicine. 18(6). 628–631. 26 indexed citations
17.
Hansen, C.R., et al.. (2011). Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis. 10(5). 318–325. 46 indexed citations
18.
Bjarnsholt, Thomas, Peter Østrup Jensen, C.R. Hansen, et al.. (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatric Pulmonology. 44(6). 547–558. 612 indexed citations breakdown →
19.
Kolpen, Mette, C.R. Hansen, Thomas Bjarnsholt, et al.. (2009). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax. 65(1). 57–62. 145 indexed citations
20.
Hansen, C.R., Tacjana Pressler, Christian Koch, & Niels Høiby. (2005). Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. Journal of Cystic Fibrosis. 4(1). 35–40. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Waters Breakdown of academic impact, for papers by Yvonne Yau Breakdown of academic impact, for papers by Miles Denton Breakdown of academic impact, for papers by Jim Manos Breakdown of academic impact, for papers by Mette Kolpen Breakdown of academic impact, for papers by Chelsie E. Armbruster Breakdown of academic impact, for papers by James E. A. Zlosnik Breakdown of academic impact, for papers by Pavel Dřevı́nek Breakdown of academic impact, for papers by Maskit Bar‐Meir Breakdown of academic impact, for papers by Dan Takeuchi
Rankless by CCL
2026